Content Not Found: Ingenta Connect
Content Not Found
Content Not Found
Unfortunately we are unable to locate the content you are looking for. It is possible
that the publisher, journal or issue is no longer hosted at Ingenta Connect, or that the link that
brought you to this page is incorrect.
Please use the
features to find the
content you are looking for.
Share Content
Access Key
Free content
Partial Free content
New content
Open access content
Partial Open access content
Subscribed content
Partial Subscribed content
Free trial content
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in.Cetuximab in hemodialysis: a case report. - Abstract - Europe PMC
Europe PMC requires Javascript to function effectively.
Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please
turn on Javascript support in your web browser and reload this page.
https://orcid.org
Search worldwide, life-sciences literature
Ibrahim T Aldoss
Troy Plumb
Weining Ken Zhen
Daniel D Lydiatt
Apar Kishor Ganti
[01 Dec ):]
Journal Article, Case Reports
BACKGROUND: Concurrent chemoradiotherapy with cisplatin is the standard therapy for patients with unresectable locally advanced head and neck squamous cell carcinoma. However, cisplatin administration in patients on hemodialysis is complicated by the need to perform hemodialysis immediately after the infusion. Concurrent chemoradiation with cetuximab has been approved in definitive treatment of locally advanced head and neck cancer. Although cetuximab is not excreted via the kidneys, its use in patients on hemodialysis has not been reported. METHODS AND RESULTS: We present the case of a 65-year-old man undergoing hemodialysis, with stage IVA squamous cell carcinoma of the hypopharynx. Given the logistics of performing hemodialysis immediately postcisplatin, he received concurrent chemoradiotherapy with cetuximab. He tolerated treatment well with minor side effects. CONCLUSION: Cetuximab can be safely used in patients with renal impairment. This is the first reported case of the use of cetuximab in a patient undergoing hemodialysis.
)- subscription required
Show all items
Show all items
Show all items
Show all items
CitePeer Related Articles
Show all items
Show all items
Show all items
Show all items
Show all items
Show all items
Show all items
Show all items
Show all items
Show all items
Show all items
Show all items
Show all items